Comments
Novartis' vaccines business gets chance to prove itself
17.11.2012. | ZURICH (Reuters) - The European Medicines Agency has thrown Novartis' loss-making vaccines business a lifeline by recommending its meningitis B shot for approval, which means the pressure is on to make the product a commercial success....
